Sign In
Buy SOPH
$4.05
-0.260 (-6.03%)
At Close: Nov 17, 2025
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
09:00am, Tuesday, 11'th Nov 2025
BOSTON , Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven p
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
08:01am, Tuesday, 11'th Nov 2025
BOSTON and SAN DIEGO , Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the
SOPHiA GENETICS SA (SOPH) Q3 2025 Earnings Call Transcript
01:56pm, Tuesday, 04'th Nov 2025
SOPHiA GENETICS SA ( SOPH ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Kellen Sanger - Head of Strategy and Investor Relations Jurgi Camblong - Co-Founder, CEO & Director
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
06:45am, Tuesday, 04'th Nov 2025
BOSTON and ROLLE, Switzerland , Nov. 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter en
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
08:00am, Tuesday, 21'st Oct 2025
BOSTON and ROLLE, Switzerland , Oct. 21, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results fo
ROLLE, Switzerland and TOKYO , Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pione
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
04:01am, Thursday, 16'th Oct 2025
BOSTON and ROLLE, Switzerland , Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a br
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
08:01am, Tuesday, 23'rd Sep 2025
SALT LAKE CITY and BOSTON , Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
08:00am, Tuesday, 23'rd Sep 2025
SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
08:00am, Monday, 22'nd Sep 2025
BOSTON , Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (L
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology
04:00am, Friday, 05'th Sep 2025
BOSTON and ROLLE, Switzerland , Sept. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced
SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript
11:19pm, Tuesday, 05'th Aug 2025
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants George A. Cardoza - Executive VP & CFO Jurgi Camblong - Co-Founder, CEO & Director Kel
SOPHiA GENETICS Reports Second Quarter 2025 Results
06:45am, Tuesday, 05'th Aug 2025
BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for t
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
06:40am, Tuesday, 05'th Aug 2025
BOSTON and ROLLE, Switzerland , Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025
08:00am, Tuesday, 22'nd Jul 2025
BOSTON and ROLLE, Switzerland , July 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its
